Comparison of the aerosol velocity and spray duration of Respimat® Soft Mist™ inhaler and pressurized metered dose inhalers

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 18, Issue 3, 2005, Pages 273-282

  Hochrainer, Dieter ^a   Hölz, Hubert ^a   Kreher, Christoph ^a   Scaffidi, Luigi ^a   Spallek, Michael ^a   Wachtel, Herbert ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Aerosol; Inhaler; MDI; Metered dose inhaler; Respimat; Spray; Spray duration; Velocity

Indexed keywords

BRONCHODILATING AGENT; CHLOROFLUOROCARBON; FENOTEROL; FLUORINATED HYDROCARBON; FLUTICASONE; IPRATROPIUM BROMIDE; PROPELLANT; SALBUTAMOL; SALMETEROL;

AEROSOL; ARTICLE; COMPARATIVE STUDY; DIFFRACTION; DRUG DELIVERY SYSTEM; HUMAN; INHALATION; METERED DOSE INHALER; OROPHARYNX; PARTICLE SIZE; TECHNIQUE; VELOCITY; VIDEORECORDING;

AEROSOL PROPELLANTS; AEROSOLS; ALBUTEROL; ANDROSTADIENES; BRONCHODILATOR AGENTS; CHLOROFLUOROCARBONS; EQUIPMENT DESIGN; FENOTEROL; HUMANS; HYDROCARBONS, FLUORINATED; IPRATROPIUM; LASERS; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; RHEOLOGY; TIME FACTORS; VIDEO RECORDING;

EID: 25844472597     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2005.18.273     Document Type: Article

References (19)

1. Ganderton, D. 1997. General factors influencing drug delivery to the lung. Respir. Med. 91:13-16.
2. Pavia, D. 1997. Efficacy and safety of inhalation therapy in chronic obstructive pulmonary disease and asthma. Respirology 2:S5-S10.
3. Zierenberg, B. 1999. Optimizing the in-vitro performance of the Respimat®. J. Aerosol Med. 12: S19-S24.
4. Zierenberg, B., J. Eicher. 2002. The Respimat, a new soft mist inhaler for delivering drugs to the lungs. In M.J. Rathbone, J. Hadgraft, M.S. Roberts, eds. Modified-Release Drug Delivery Technology. Marcel Dekker, New York, 925-933.
5. Dalby, R., M. Spallek, T. Voshaar. 2004. A review of the development of Respimat® Soft Mist™ Inhaler. Int. J. Pharm. 283:1-9.
6. Newman, S.P., K.P. Steed, S.J. Reader, et al. 1996. Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebuliser. J. Pharm. Sci. 85:960-964.
7. Steed, K.P., L.J. Towse, B. Freund, et al. 1997. Lung and oropharyngeal depositions of fenoterol hydrobromide delivered from the prototype III hand-held multidose Respimat nebuliser. Eur. J. Pharm. Sci. 5:55-61.
8. Newman, S.P., J. Brown, K.P. Steed, et al. 1998. Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of Respimat with conventional metered-dose inhalers with and without spacer devices. Chest 113:957-963.
9. Heyder, J. 1990. Ablagerungen von Aerosolteilchen im Atemtrakt des Menschen. In V. Sill and D. Nolte, eds. Neue Wege in der Inhalationstherapie obstruktiver Atemwegserkrankungen. Dustri-Berlag, München.
10. Köhler, D., and W. Fleischer. 2000. Theorie und Praxis der Inhalationstherapie. Arcis Verlag, München.
11. Newman, S.P., D. Pavia, F. Moren, et al. 1981. Deposition of pressurised aerosols in the human respiratory tract. Thorax 36:52-55.
12. Dhand, R., S.K. Malik, M. Balakrishnan, et al. 1988. High speed photographic analysis of aerosols produced by metered dose inhalers. J. Pharm. Pharmacol. 40:429-430.
13. de Boer, A.H., D. Gjaltema, P. Hagedoorn, et al. 2002. Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols. Int. J. Pharm. 249:233-245.
14. de Boer, A.H., D. Gjaltema, P. Hagedoorn, et al. 2002. Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique. Int. J. Pharm. 249:219-231.
15. Willeke, K., and P.A. Baron. 1992. Aerosol Measurement: Principles, Techniques, and Applications. John Wiley, New York.
16. van Noord, J.A., J.J. Smeets, J.P.H.M. Creemers, et al. 2000. Delivery of fenoterol via Respimat®, a novel "soft mist" inhaler. Respiration 67:672-678.
17. Vincken, W., T. Bantje, M.V. Middle, et al. 2004. Long-term efficacy and safety of ipratropium bromide plus fenoterol via Respimat® Soft Mist™ Inhaler (SMI) versus a pressurised metered dose inhaler in asthma. Clin. Drug. Invest. 24:17-28.
18. von Berg, A., P.M. Jeena, P.A. Soemantri, et al. 2004. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat® Soft Mist™ Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma. Pediatr. Pulmonol. 37: 264-272.
19. Kilfeather, S.A., H.H. Ponitz, E. Beck, et al. 2004. Improved delivery of ipratropium bromide/fenoterol from Respimat® Soft Mist™ Inhaler in patients with COPD. Respir. Med. 98:387-397.